Are you saying that AVXL will not dilute to conduct upcoming P2/3 trial and then P3 trial? Show me that they can conduct 450 patient multi year trial with current 23 million funds -
Also - is the product approved to go to P3 - heck it is starting P2/3
So what you say is illogical and you cannot refute my statements